KMDA logo

Kamada (KMDA)

Profile

Full Name

Kamada Ltd.

Ticker Symbol

KMDA

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Israel

IPO

May 31, 2013

Indexes

Not included

Website

http://www.kamada.com

Employees

420

Key Details

Price

$6.07(+2.71%)

Market cap

$349.06M(Small cap)

Last Dividend

$0.20

TTM Dividend yield

3.29%

Annual revenue

$160.95M(+12.93% YoY)

Annual EPS

$0.25(+66.67% YoY)

PE ratio

23.35

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.07
KMDA price is $6.07

30-Day Relative Volume

0.77
KMDA 30-day relative volume is 0.77

Price Performance

Price Most recent change

+2.71%
KMDA price was up +2.71% on Apr 11, 2025

Price YTD change

-0.33%
KMDA price is down -0.33% since January 1st

Price 1-year change

+16.73%
KMDA price is up +16.73% year-on-year

Price 3-year change

+7.43%
KMDA price is up +7.43% over the past 3 years

Price Range

Price All-time high

$17.95
KMDA price is currently -66.18% below its historical high of $17.95

Price 3-year low

$3.72
KMDA price is currently +63.17% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$349.06M
KMDA market capitalization is $349.06 million

Market cap 3-year change

+37.9%
KMDA market capitalization is up +37.9% over the past 3 years

Market cap All-time high

$629.30M
KMDA market capitalization is currently -44.53% below its historical high of $629.30 million

Market cap sector rank

65%
KMDA market capitalization is higher than 65% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.04%
KMDA shares outstanding is up +0.04% year-on-year

Shares Outstanding 3-Year Change

+28.36%
KMDA shares outstanding is up +28.36% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.68
KMDA beta is 0.68

200-day SMA

$6.10
KMDA price is currently -0.42% below its 200-day simple moving average

50-day SMA

$6.98
KMDA price is currently -13.09% below its 50-day simple moving average

RSI

38.75
KMDA 14-day relative strength index is 38.75

Volume

0.77
KMDA 30-day relative volume is 0.77

ATR

$0.35
KMDA average true range is $0.35

10-day Historical Volatility

52.89%
KMDA 10-day historical volatility is 52.89%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.20
KMDA last dividend was $0.20 per share, with an ex-dividend date of March 17, 2025

Next Dividend

-
KMDA next dividend has not yet been announced

Dividend per share

Dividend per share

-
KMDA annual dividend per share value is unknown

Dividend per share Sector Rank

-
KMDA annual dividend per share is unknown

Dividend per share 1-Year Change

-
KMDA annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
KMDA annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
KMDA annual dividend yield value is unknown

Dividend yield Sector Rank

-
KMDA annual dividend yield is unknown

Other

Payout ratio

-
KMDA annual payout ratio value is unknown

Dividends paid

-
KMDA annual dividends paid value is unknown

Free cash flow

$36.85M
KMDA annual free cash flow is $36.85 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$160.95M
KMDA annual revenue is $160.95 million

Revenue Analysts estimate

$656.25M
KMDA annual revenue is currently -75.47% lower than the consensus analysts' forecast

Revenue 1-year change

+12.93%
KMDA annual revenue is up +12.93% year-on-year

Revenue Sector rank

61.03%
KMDA annual revenue is higher than 61.03% of companies in Healthcare sector

EPS

EPS

$0.25
KMDA annual earnings per share is $0.25

EPS Analysts estimate

$0.30
KMDA annual earnings per share is currently -15.97% lower than the consensus analysts' forecast

EPS 1-year change

+66.67%
KMDA annual earnings per share is up +66.67% year-on-year

EPS Sector rank

85.22%
KMDA annual earnings per share is higher than 85.22% of companies in Healthcare sector

Profit

Gross profit

$69.97M
KMDA annual gross profit is $69.97 million

Gross margin

43.47%
KMDA annual gross profit margin is 43.47%

Operating profit

$20.05M
KMDA annual operating income is $20.05 million

Operating margin

12.46%
KMDA annual operating profit margin is 12.46%

Net income

$14.46M
KMDA annual net profit is $14.46 million

Net margin

8.99%
KMDA annual net profit margin is 8.99%

Expenses

Total expenses

$140.90M
KMDA annual total expenses is $140.90 million

Operating expenses

$49.92M
KMDA annual total operating expenses is $49.92 million

Cost of goods sold

$90.99M
KMDA annual cost of goods sold is $90.99 million

Selling, general & administrative expenses

$30.83M
KMDA annual SGA is $30.83 million

Depreciation and amortization

$13.81M
KMDA annual depreciation & amortization is $13.81 million

Interest expense

$660.00K
KMDA annual interest expense is $660.00 thousand

Income tax

-$1.13M
KMDA annual income tax is -$1.13 million

EBIT & EBITDA

EBIT

$13.99M
KMDA annual earnings before interest & taxes is $13.99 million

EBITDA

$27.80M
KMDA annual EBITDA is $27.80 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$372.25M
KMDA annual total assets is $372.25 million

Non current assets

$187.91M
KMDA annual long term assets is $187.91 million

Current assets

$184.35M
KMDA annual total current assets is $184.35 million

Cash and cash equivalents

$78.44M
KMDA annual cash & cash equivalents is $78.44 million

Accounts receivable

$21.39M
KMDA annual accounts receivable is $21.39 million

Inventory

$78.82M
KMDA annual inventory is $78.82 million

Liabilities

Total liabilities

$112.79M
KMDA annual total liabilities is $112.79 million

Long term liabilities

$63.40M
KMDA annual total long term liabilities is $63.40 million

Current liabilities

$49.39M
KMDA annual total current liabilities is $49.39 million

Accounts payable

$27.73M
KMDA annual accounts payable is $27.73 million

Debt

Total debt

$11.06M
KMDA annual total debt is $11.06 million

Total debt 1-year change

+25.39%
KMDA annual total debt is up +25.39% year-on-year

Long term debt

$9.43M
KMDA annual long term debt is $9.43 million

Short term debt

$1.63M
KMDA annual short term debt is $1.63 million

Equity & Capital

Shareholders equity

$259.46M
KMDA annual stockholders equity is $259.46 million

Book value

$259.46M
KMDA annual book value is $259.46 million

Retained earnings

-$25.74M
KMDA annual retained earnings is -$25.74 million

Working capital

$134.96M
KMDA annual working capital is $134.96 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$47.59M
KMDA annual cash flow from operations is $47.59 million

Cash from operations 1-year change

+1002.99%
KMDA annual cash flow from operations is up +1002.99% year-on-year

Cash from investing

-$10.74M
KMDA annual cash flow from investing activities is -$10.74 million

Cash from investing 1-year change

-83.79%
KMDA annual cash flow from investing activities is down -83.79% year-on-year

Cash from financing

-$13.91M
KMDA annual cash flow from financing activities is -$13.91 million

Cash from financing 1-year change

-161.34%
KMDA annual cash flow from financing activities is down -161.34% year-on-year

CAPEX

CAPEX

$10.74M
KMDA annual capital expenditures is $10.74 million

CAPEX 1-year change

+83.59%
KMDA annual capital expenditures is up +83.59% year-on-year

Free Cash Flow

Free cash flow

$36.85M
KMDA annual free cash flow is $36.85 million

Free cash flow 1-year change

+2500.91%
KMDA annual free cash flow is up +2500.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

43.47%
KMDA annual gross profit margin is 43.47%

Operating margin

12.46%
KMDA annual operating profit margin is 12.46%

Net margin

8.99%
KMDA annual net profit margin is 8.99%

ROA & ROE

ROA

3.98%
KMDA annual return on assets is 3.98%

ROE

5.74%
KMDA annual return on equity is 5.74%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

23.35
KMDA price to earnings ratio is 23.35

PE ratio Sector rank

45.1%
KMDA price to earnings ratio is higher than 45.1% of companies in Healthcare sector

PB Ratio

PB ratio

1.35
KMDA price to book ratio is 1.35

PB ratio Sector rank

52.06%
KMDA price to book ratio is higher than 52.06% of companies in Healthcare sector

PS Ratio

PS ratio

2.17
KMDA price to sales ratio is 2.17

PS ratio Sector rank

44.74%
KMDA price to sales ratio is higher than 44.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$281.68M
KMDA enterprise value is $281.68 million

Enterprise value Sector rank

62.9%
KMDA enterprise value is higher than 62.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.13
KMDA EV/EBITDA is 10.13

EV/EBITDA Sector rank

82.73%
KMDA EV/EBITDA is higher than 82.73% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.73
KMDA annual current ratio is 3.73

Quick ratio

2.14
KMDA annual quick ratio is 2.14

Leverage

Debt to equity

0.00
KMDA annual debt to equity ratio is 0.00

Interest coverage ratio

21.20
KMDA annual interest coverage ratio is 21.20

Risk & Stability

Piotroski F-Score

7
KMDA piotroski f-score is 7

Altman Z-Score

2.75
KMDA altman z-score is 2.75

Analyst ratings

Recent major analysts updates

Mar 21, 25 Benchmark
Buy
Mar 6, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jul 3, 24 Stifel
Buy
May 9, 24 HC Wainwright & Co.
Buy
Mar 7, 24 HC Wainwright & Co.
Buy
Nov 14, 23 HC Wainwright & Co.
Buy
Aug 17, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

CELC logo
Celcuity (CELC)
ORIC logo
ORIC Pharmaceuticals (ORIC)
Sionna Therapeutics (SION)
ERAS logo
Erasca (ERAS)
Alumis (ALMS)
CYH logo
Community Health Systems (CYH)
DCTH logo
Delcath Systems (DCTH)
PHAT logo
Phathom Pharmaceuticals (PHAT)
ALT logo
Altimmune (ALT)
  • What is the ticker symbol for Kamada?
  • Does Kamada pay dividends?
  • What sector is Kamada in?
  • What industry is Kamada in?
  • What country is Kamada based in?
  • When did Kamada go public?
  • Is Kamada in the S&P 500?
  • Is Kamada in the NASDAQ 100?
  • Is Kamada in the Dow Jones?
  • When was Kamada's last earnings report?
  • When does Kamada report earnings?
  • Should I buy Kamada stock now?

What is the ticker symbol for Kamada?

The ticker symbol for Kamada is NASDAQ:KMDA

Does Kamada pay dividends?

Yes, Kamada pays dividends. The last payment was $0.20, with an ex-dividend date on March 17, 2025

What sector is Kamada in?

Kamada is in the Healthcare sector

What industry is Kamada in?

Kamada is in the Drug Manufacturers - Specialty & Generic industry

What country is Kamada based in?

Kamada is headquartered in Israel

When did Kamada go public?

Kamada's initial public offering (IPO) was on May 31, 2013

Is Kamada in the S&P 500?

No, Kamada is not included in the S&P 500 index

Is Kamada in the NASDAQ 100?

No, Kamada is not included in the NASDAQ 100 index

Is Kamada in the Dow Jones?

No, Kamada is not included in the Dow Jones index

When was Kamada's last earnings report?

Kamada's most recent earnings report was on Mar 5, 2025

When does Kamada report earnings?

The next expected earnings date for Kamada is May 1, 2025

Should I buy Kamada stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page